Article and Video CATEGORIES

Cancer Journey

Search By

Immunotherapy for Squamous Non-Small Cell Lung Cancer
Author
GRACE Videos and Articles

ASCO 2015 Highlights 01

 

Research released at the 2015 American Society of Clinical Oncology (ASCO) annual meeting showed great promise for squamous cell lung cancer patients taking the immunotherapy drug Opdivo (nivolumab). But can we predict which patients will do well on it?

[powerpress]

Download Transcript

Please feel free to offer comments and raise questions in our Discussion Forums.

 

Next Previous link

Previous PostNext Post

Related Content

Article
The article describes the AVO treatment, a combination therapy for Chronic Lymphocytic Leukemia (CLL), particularly for high-risk patients. CLL is a slow-growing cancer where abnormal white blood cells accumulate. "High-risk" CLL refers to cases with specific genetic changes (e.g., in TP53) that make the disease harder to treat.
Image
2025 Spanish Targeted Therapy in Lung Cancer Patient Forum
Article
Da click aquí para más información y para registrarte ahora

Forum Discussions

I don't know what to do. No insurance

Hi Ascardino, Welcome to Grace. I'm so sorry to hear of your situation.  While we don't have specific info or expertise on ovarian cancer, I did some searching for information.  It...

Recent Comments

JOIN THE CONVERSATION
Hi Ascardino, Welcome to…
By JanineT GRACE … on
I don't know what to do. No…
By Ascardino on
Hi Hopish hope,  Welcome to…
By JanineT GRACE … on